chartexchange

In Combination with a GLP-1, ERX Pharmaceuticals' First-in-Class Oral Leptin Sensitizer, ERX1000, Showed Significantly Enhanced Weight Loss, Improved Overall Metabolic Health, and Increased Muscle Strength in Diet-Induced Obese Mice

PR Newswire | Nov 16, 2026 9:00 AM EST

According to a new study, the combination therapy resulted in a placebo-corrected body weight reduction of 36% over five weeks, compared to 14% for semaglutide alone and 18% for ERX1000 Combination therapy also improved muscle strength 32% versus the placebo, while increasing the lean...

Read original article